Phase II study of gemcitabine and cisplatin in women with taxane-failed metastatic breast cancer (MBC)

被引：0
|
作者：
Wang, T. [1 ]
Jiang, Z. [1 ]
Song, S. [1 ]
Shen, G. [1 ]
Zhang, S. [1 ]
Wu, S. [1 ]
Zeng, M. [1 ]
机构：
[1] 307 Hosp Affiliated, Mil Med Acad, Ctr Canc, Beijing, Peoples R China
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：127 / 127
页数：1
相关论文
共 50 条
  • [31] A PHASE-II STUDY OF CHIP IN METASTATIC BREAST-CANCER (MBC)
    HORTOBAGYI, G
    HOLMES, F
    FRYE, D
    HUG, V
    FRASCHINI, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 198 - 198
  • [32] Interim analysis of a Phase II study of biochemotherapy in metastatic breast cancer (MBC)
    Lal, A.
    Alidina, A.
    EJC SUPPLEMENTS, 2005, 3 (02): : 131 - 131
  • [33] Phase II Study of Gemcitabine Monotherapy as a Salvage Treatment for Japanese Metastatic Breast Cancer Patients after Anthracycline and Taxane Treatment
    Suzuki, Yasuhiro
    Tokuda, Yutaka
    Fujiwara, Yasuhiro
    Iwata, Hiroji
    Sasaki, Yasutsuna
    Saji, Shigehira
    Aogi, Kenjiro
    Nambu, Yoshihiro
    Suri, Ajit
    Saeki, Toshiaki
    Takashima, Shigemitsu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (11) : 699 - 706
  • [34] Phase II trial of ixabepilone in patients with metastatic breast cancer (MBC) who are resistant to an anthracycline, a taxane and capecitabine.
    Thomas, E.
    Perez, E. A.
    Mukhopadhyay, P.
    Lerzo, G.
    Pivot, X.
    Bosserman, L. D.
    Mullaney, B.
    Vahdat, L.
    Hortobagyi, G. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 42S - 42S
  • [35] A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer MBC
    Bensalem, A
    Bouzid, K
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 1) : S21 - S21
  • [36] Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer
    Meyerhardt, Jeffrey A.
    Zhu, Andrew X.
    Stuart, Keith
    Ryan, David P.
    Blaszkowsky, Lawrence
    Lehman, Nicole
    Earle, Craig C.
    Kulke, Matthew H.
    Bhargava, Pankaj
    Fuchs, Charles S.
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (02) : 564 - 570
  • [37] Phase II study of combination chemotherapy with gemcitabine and cisplatin for patients with metastatic pancreatic cancer
    Ueno, Hideki
    Okusaka, Takuji
    Ikeda, Masafumi
    Morizane, Chigusa
    Ogura, Takashi
    Hagihara, Atsushi
    Tanaka, Tsutomu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (07) : 515 - 520
  • [38] A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)
    A Bensalem
    K Bouzid
    Breast Cancer Research, 7
  • [39] Phase-II Study of Gemcitabine and Cisplatin in Patients with Metastatic Biliary and Gallbladder Cancer
    Jeffrey A. Meyerhardt
    Andrew X. Zhu
    Keith Stuart
    David P. Ryan
    Lawrence Blaszkowsky
    Nicole Lehman
    Craig C. Earle
    Matthew H. Kulke
    Pankaj Bhargava
    Charles S. Fuchs
    Digestive Diseases and Sciences, 2008, 53 : 564 - 570
  • [40] Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane
    Park, Ji Soo
    Jeung, Hei-Cheul
    Rha, Sun Young
    Ahn, Joong Bae
    Kang, Beodeul
    Chon, Hong Jae
    Hong, Min Hee
    Lim, Seungtaek
    Yang, Woo Ick
    Nam, Chung Mo
    Chung, Hyun Cheol
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (04) : 799 - 808
12345